• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NMDA受体抑制剂氯胺酮在急慢性口面部疼痛中的作用。

Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain.

作者信息

Mathisen Lene Cecilie, Skjelbred Per, Skoglund Lasse A, Øye Ivar

机构信息

Department of Pharmacology, Oslo University School of Medicine, Oslo Norway Department of Maxillofacial Surgery, Ullevål Hospital, Oslo Norway Section of Dental Pharmacology and Pharmacotherapeutics, University of Oslo, Oslo Norway.

出版信息

Pain. 1995 May;61(2):215-220. doi: 10.1016/0304-3959(94)00170-J.

DOI:10.1016/0304-3959(94)00170-J
PMID:7659431
Abstract

We examined the analgesic effect of racemic ketamine and its 2 enantiomers in 16 female patients (age: 20-29 years) suffering acute pain after oral surgery and in 7 female patients (age: 42-79 years) suffering chronic neuropathic orofacial pain. All 3 forms of ketamine consistently relieved postoperative pain, (S)-ketamine being 4 times more potent than (R)-ketamine. The analgesic effect was maximal 5 min after i.m. injection and lasted for about 30 min. The 7 patients with neuropathic pain received ketamine at one or several occasions. Four patients (age: 54-79 years) who had suffered pain for more than 5 years did not experience an analgesic effect, whereas 3 patients (age: 42-53 years) who had suffered pain for less than 3 years reported pain relief lasting from 24 h to 3 days. The individual type of response did not depend on the form of ketamine used. The mental side effects were qualitatively similar for the 3 forms of ketamine. Relative to the analgesic effect (S)-ketamine caused more disturbing side effects than did (R)-ketamine. The mean serum concentration of each form of ketamine at the time of maximal effect was close to the approximate Kd value for PCP site occupancy by that particular form. This is in concert with the hypothesis that the effect of ketamine on acute nociceptive pain is due to N-methyl-D-aspartate (NMDA) receptor inhibition and adds to the evidence that NMDA receptors are important for the perception of acute, nociceptive pain in humans.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们研究了消旋氯胺酮及其两种对映体对16名(年龄20 - 29岁)口腔手术后遭受急性疼痛的女性患者以及7名(年龄42 - 79岁)患有慢性神经性口面部疼痛的女性患者的镇痛效果。氯胺酮的所有三种形式均能持续缓解术后疼痛,其中(S)-氯胺酮的效力是(R)-氯胺酮的4倍。肌肉注射后5分钟镇痛效果达到最大,并持续约30分钟。7名神经性疼痛患者曾一次或多次接受氯胺酮治疗。4名疼痛超过5年的患者(年龄54 - 79岁)未体验到镇痛效果,而3名疼痛少于3年的患者(年龄42 - 53岁)报告疼痛缓解持续24小时至3天。个体反应类型不取决于所用氯胺酮的形式。氯胺酮的三种形式在精神方面的副作用在性质上相似。相对于镇痛效果,(S)-氯胺酮比(R)-氯胺酮引起的不良副作用更多。每种形式的氯胺酮在最大效应时的平均血清浓度接近该特定形式占据苯环己哌啶(PCP)位点的近似解离常数(Kd)值。这与氯胺酮对急性伤害性疼痛的作用是由于N - 甲基 - D - 天冬氨酸(NMDA)受体抑制的假设一致,并进一步证明NMDA受体对人类急性伤害性疼痛的感知很重要。(摘要截选至250字)

相似文献

1
Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain.NMDA受体抑制剂氯胺酮在急慢性口面部疼痛中的作用。
Pain. 1995 May;61(2):215-220. doi: 10.1016/0304-3959(94)00170-J.
2
Interindividual differences in the analgesic response to ketamine in chronic orofacial pain.慢性口面部疼痛患者对氯胺酮镇痛反应的个体差异。
Eur J Pain. 2001;5(3):233-40. doi: 10.1053/eujp.2001.0232.
3
Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.N-甲基-D-天冬氨酸受体抑制剂氯胺酮对慢性疼痛患者的长期镇痛作用。
J Pharmacol Exp Ther. 1999 May;289(2):1060-6.
4
Evidence of a role for NMDA receptors in pain perception.N-甲基-D-天冬氨酸受体在痛觉感知中作用的证据。
Eur J Pharmacol. 1990 Oct 23;187(3):513-8. doi: 10.1016/0014-2999(90)90379-k.
5
Effects of the NMDA receptor antagonist ketamine in electrically induced A delta-fiber pain.N-甲基-D-天冬氨酸(NMDA)受体拮抗剂氯胺酮对电诱导Aδ纤维痛觉的影响。
Methods Find Exp Clin Pharmacol. 2000 Apr;22(3):185-9.
6
Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.非选择性和 NR2B 选择性 N-甲基-D-天冬氨酸受体拮抗剂在急性和神经性疼痛中产生镇痛作用,并长期缓解痛觉过敏。
Anesthesiology. 2011 Jul;115(1):165-74. doi: 10.1097/ALN.0b013e31821bdb9b.
7
Functional interaction between N-methyl-D-aspartate receptor and ascorbic acid during neuropathic pain induced by chronic constriction injury of the sciatic nerve.坐骨神经慢性压迫损伤诱导的神经性疼痛过程中N-甲基-D-天冬氨酸受体与抗坏血酸之间的功能相互作用
J Basic Clin Physiol Pharmacol. 2017 Nov 27;28(6):601-608. doi: 10.1515/jbcpp-2017-0015.
8
Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade.氯胺酮诱导的N-甲基-D-天冬氨酸受体阻断缓解舌咽神经痛
Neurosurgery. 1997 Aug;41(2):505-8. doi: 10.1097/00006123-199708000-00043.
9
Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.大鼠弗氏完全佐剂诱导炎症后氯胺酮和阿芬太尼的研究。
Clin Exp Pharmacol Physiol. 2007 May-Jun;34(5-6):414-20. doi: 10.1111/j.1440-1681.2007.04581.x.
10
Ketamine potentiates analgesic effect of morphine in postoperative epidural pain control.氯胺酮可增强吗啡在术后硬膜外镇痛中的镇痛效果。
Reg Anesth. 1996 Nov-Dec;21(6):534-41.

引用本文的文献

1
Pharmacokinetics, Safety, and Tolerability of (R)-Ketamine Hydrochloride Injection, a Novel Rapid-Acting Antidepressant, in Healthy Chinese Subjects.新型速效抗抑郁药(R)-盐酸氯胺酮注射液在健康中国受试者中的药代动力学、安全性和耐受性
Pharmaceuticals (Basel). 2025 Jul 21;18(7):1079. doi: 10.3390/ph18071079.
2
Molecular pathways of ketamine: A systematic review of immediate and sustained effects on PTSD.氯胺酮的分子途径:对创伤后应激障碍即时和持续影响的系统评价
Psychopharmacology (Berl). 2025 Jun;242(6):1197-1243. doi: 10.1007/s00213-025-06756-4. Epub 2025 Mar 17.
3
Arketamine: a scoping review of its use in humans.
阿氯胺酮:关于其在人体应用的范围综述。
Eur Arch Psychiatry Clin Neurosci. 2024 Dec 16. doi: 10.1007/s00406-024-01945-2.
4
Antidepressants enter cells, organelles, and membranes.抗抑郁药进入细胞、细胞器和膜。
Neuropsychopharmacology. 2024 Jan;49(1):246-261. doi: 10.1038/s41386-023-01725-x. Epub 2023 Oct 2.
5
Application of Ketamine in Pain Management and the Underlying Mechanism.氯胺酮在疼痛管理中的应用及作用机制。
Pain Res Manag. 2023 Aug 16;2023:1928969. doi: 10.1155/2023/1928969. eCollection 2023.
6
A systematic review of the efficacy of ketamine for craniofacial pain.氯胺酮治疗颅面部疼痛疗效的系统评价
Can J Pain. 2023 Jun 26;7(1):2210167. doi: 10.1080/24740527.2023.2210167. eCollection 2023.
7
Risk of esketamine anesthesia on the emergence delirium in preschool children after minor surgery: a prospective observational clinical study.小儿短小手术全身麻醉苏醒期谵妄的风险:前瞻性观察性临床研究。
Eur Arch Psychiatry Clin Neurosci. 2024 Jun;274(4):767-775. doi: 10.1007/s00406-023-01611-z. Epub 2023 Apr 18.
8
Continuous Ketamine Infusion as a Treatment for Refractory Facial Pain.持续输注氯胺酮治疗顽固性面部疼痛。
Cureus. 2023 Mar 1;15(3):e35638. doi: 10.7759/cureus.35638. eCollection 2023 Mar.
9
Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the "KetHead" trial.多中心随机对照试验方案,评估静脉注射氯胺酮治疗慢性每日头痛的疗效和安全性:“KetHead”试验。
Trials. 2023 Mar 1;24(1):155. doi: 10.1186/s13063-023-07186-3.
10
Esketamine Anesthetizes Mice With a Similar Potency to Racemic Ketamine.艾氯胺酮麻醉小鼠的效力与消旋氯胺酮相似。
Dose Response. 2023 Feb 11;21(1):15593258231157563. doi: 10.1177/15593258231157563. eCollection 2023 Jan-Mar.